Improving access to high‐cost cancer drugs in Latin America: Much to be done

Lack of access to high‐cost medications is a complex issue at the intersection of economics, medicine, politics, and ethics, and it poses a significant threat to global health care. The problem is even more significant in low‐ and middle‐income countries, such as those in Latin America, where governments and individuals struggle to pay for products that are priced at several times the level of their per capita gross domestic product. In this...